Smurfit-backed firm seeks €10m

Darren Cunningham, chief executive, and Dr Michael O’Neill, R&D manager, Inflection Biosciences

Company: Inflection Biosciences

Done deal: €2.5m investment

The clincher:“I am now actively engaging with a selection of new investors we would like to bring on board to help us transition through a VC-type investment” – Darren Cunningham, Inflection Biosciences

Inflection Biosciences, the biotech start-up backed by Michael Smurfit, is planning to seek VC funding of more than €10 million next year to finance the commercialisation of the targeted cancer treatments it has been ...